EU
#WHO convening experts on drugs and vaccines to set Coronavirus research agenda
Hundreds of experts will meet in Geneva next Tuesday and Wednesday (11-12 February) to set research and development priorities for coronavirus drugs, diagnostics and vaccines to combat the outbreak, the World Health Organization (WHO) said on Wednesday (5 February), writes Stephanie Nebehay.
“There are no proven effective therapeutics for novel coronavirus,” Dr. Mike Ryan, executive director of WHO emergencies programme, told a news conference.
WHO epidemiologist Dr. Maria van Kerkhove said participants would include experts in clinical investigations and research into an animal source of the virus which emerged at a market in the central Chinese city of Wuhan.
“We want to bring the best minds, people who have experience in this so come around a comprehensive research agenda around coronavirus,” she said.
WHO director-general Tedros Adhanom Ghebreyesus said a multinational WHO-led team would go to China very soon to work with Chinese authorities in tackling the outbreak. He gave no details.
A total of 24,363 confirmed cases have been counted in China, including 490 deaths, Tedros said. The past 24 hours had seen the most cases in a single day since the outbreak started.
Outside China there have been 191 cases in 24 countries and one death in the Philippines, WHO figures show.
The WHO-led mission may include experts from the U.S. Centers for Disease Control and Prevention (CDC).
Some 20 agencies in the tourism and travel industry, including IATA, ICAO and the U.N.’s World Tourism Organization as well as several airlines, took part in a teleconference on Wednesday to discuss concerns including protection of crews and passengers when flights to and from China resume, she said.
Share this article:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
